Woodline Partners’s CARGO Therapeutics CRGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-846,859
Closed -$3.45M 946
2025
Q1
$3.45M Sell
846,859
-154,275
-15% -$1.03M 0.02% 587
2024
Q4
$14.4M Sell
1,001,134
-10,341
-1% -$188K 0.1% 272
2024
Q3
$18.7M Buy
+1,011,475
New +$18.1M 0.16% 201

Other funds holding CRGX

Woodline Partners's CRGX Position: Q2 2025 in Review

Woodline Partners sold out of CARGO Therapeutics (CRGX) in Q2 2025, closing a stake of 846,859 shares — an estimated $3.45M sold.

Woodline Partners first reported a position in CRGX in Q3 2024 and held it in 3 quarters. The position peaked at $18.7M in Q3 2024. 116 funds tracked by Wall St. Rank hold CRGX as of Q2 2025.

  • Woodline Partners reported no remaining CARGO Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Woodline Partners sold 846,859 CARGO Therapeutics shares in Q2 2025, an estimated $3.45M.
  • Woodline Partners first reported a position in CARGO Therapeutics in Q3 2024 and held it in 3 quarters.
  • Woodline Partners's CARGO Therapeutics position peaked at $18.7M in Q3 2024.
  • 116 funds tracked by Wall St. Rank held CARGO Therapeutics as of Q2 2025.

Based on Woodline Partners's 13F filing for Q2 2025, filed 14 Aug 2025.